Roche Molecular Systems Group Engineering Manager Salaries in Coeur D Alene, ID
The average Roche Molecular Systems Group Engineering Manager in Coeur D Alene, ID earns an estimated $206,214 annually, which includes an estimated base salary of $165,684 with a $40,531 bonus. Roche Molecular Systems' Group Engineering Manager compensation is $35,777 more than the US average for a Group Engineering Manager. Group Engineering Manager salaries at Roche Molecular Systems in Coeur D Alene, ID can range from $100,000 - $490,000.
In Coeur D Alene, ID, The Engineering Department at Roche Molecular Systems earns $9,310 more on average than the Design Department.
Last updated 2 years ago.
- $165,684
- avg. base
- $40,531
- avg. bonus
Group Engineering Manager Salaries at Roche Molecular Systems
In Coeur D Alene, ID, Group Engineering Managers earn $3,830 more than Group Engineering Managers, and $9,067 less than Directors of Engineering.
Compensation at Roche Molecular Systems by Department
In Coeur D Alene, ID, The Engineering Department averages $9,310 more than the Design Department, and $5,243 less than the Business Development Department
Group Engineering Manager Compensation by Gender (All Companies)
The average female Group Engineering Manager at companies similar size to Roche Molecular Systems reported making $161,172, while the average male Group Engineering Manager at similar sized companies reported making $208,878.
Group Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Group Engineering Manager at companies similar size to Roche Molecular Systems reported making $241,524, while the average African American/Black Group Engineering Manager at similar sized companies reported making $138,333.
How Group Engineering Managers at Roche Molecular Systems Rate Their Compensation
The majority of Group Engineering Managers at Roche Molecular Systems believe they're compensated fairly. 100% of Group Engineering Managers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
